收藏切换
Analysis of the impact of the national volume-based procurement policy on the use of anti-tumor drugs in a hospital
收藏切换
Lijie WANG, Erjun XU, Xin LYU, Xiaomin SUN, Qimin XU
World Clinical Drug | 2024, 45(10) : 1058 - 1066
Less
收藏切换
World Clinical Drug | 2024, 45(10): 1058-1066
• Article •
Analysis of the impact of the national volume-based procurement policy on the use of anti-tumor drugs in a hospital
Full
Lijie WANG, Erjun XU, Xin LYU, Xiaomin SUN, Qimin XU
Affiliations
  • Department of Pharmacy, The Second People's Hospital of Jiaozuo, Jiaozuo 454000, Henan Province, China
Published: 2024-10-10 doi: 10.13683/j.wph.2024.10.010
Outline
收藏切换
Objective

To explore the effect of national volume-based procurement (NVBP) policy on the use of anti-tumor drugs in a tertiary A general hospital, and to provide rational advices for improving quantity of drug policies and enhancing hospital pharmaceutical management.

Methods

Descriptive statistical methods were used to compare usage quantity, consumption volumes, defined daily dose system (DDDs), defined daily dose cost (DDDc), daily cost ratio and B/A before and after the implementation of NVBP policy of anti-tumor drugs.

Results

After the implementation of NVBP policy, the total usage amount of anti-tumor drugs increased from 49 666.35 g to 105 870.91 g, with an increase of 113.16%, the total consumption sum decreased from CNY 13.699 9 million to CNY 4.917 9 million, with a decrease of 64.10%. The DDDc of anti-tumor drugs all showed a decreasing trend, with the daily cost ratio was less than 1.0, a total of 33.814 4 million was saved in expenses, the proportion of usage amount, DDDs, and consumption sum of bid-winning tumor drugs were 100.00%, 99.38%, and 99.30%, respectively.

Conclusion

After the implementation of the national volume-based procurement policy in a tertiary comprehensive hospital, the cost of anti-tumor drugs has significantly decreased, which significantly reduces the economic burden on patients, reduces the operating costs of the hospital, and promotes a more reasonable distribution of medical insurance funds.

volume-based procurement  /  anti-tumor drug  /  defined daily dose system  /  defined daily dose cost  /  medication analysis
王利杰, 许二俊, 吕昕, 孙晓敏, 许琪敏. 国家组织药品集中带量采购政策对某院抗肿瘤药物使用影响分析. 世界临床药物, 2024 , 45 (10) : 1058 -1066 . DOI: 10.13683/j.wph.2024.10.010
Lijie WANG, Erjun XU, Xin LYU, Xiaomin SUN, Qimin XU. Analysis of the impact of the national volume-based procurement policy on the use of anti-tumor drugs in a hospital[J]. World Clinical Drug, 2024 , 45 (10) : 1058 -1066 . DOI: 10.13683/j.wph.2024.10.010
Year 2024 volume 45 Issue 10
15
1
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.10.010
  • Receive Date:2024-06-21
  • Online Date:2026-11-17
  • Published:2024-10-10
Article Data
Affiliations
History
  • Received:2024-06-21
Funding
Affiliations
    Department of Pharmacy, The Second People's Hospital of Jiaozuo, Jiaozuo 454000, Henan Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.10.010
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT